Recombinant Human KAT2A / GCN5 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human KAT2A / GCN5 protein is a Human Fragment protein, in the 411 to 837 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
GCN5, GCN5L2, KAT2A, Histone acetyltransferase KAT2A, General control of amino acid synthesis protein 5-like 2, Histone acetyltransferase GCN5, Histone glutaryltransferase KAT2A, Histone succinyltransferase KAT2A, Lysine acetyltransferase 2A, STAF97, hGCN5
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human KAT2A / GCN5 protein (AB111648)
3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain.
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human KAT2A / GCN5 protein (AB111648)
15% SDS-PAGE analysis of ab111648 (3 μg)
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KAT2A/GCN5 participates in several cellular processes as part of larger protein complexes. It is a component of the SAGA (Spt-Ada-Gcn5 acetyltransferase) and TFTC (TBP-free TAF-containing complex) both involved in transcription regulation. Through these complexes KAT2A influences gene expression by acetylating histone residues which in turn affects the recruitment of other transcriptional activators or repressors. This activity also links it to non-histone substrates that support DNA damage repair and cellular senescence.
Pathways
KAT2A/GCN5 is integrally connected to the regulation of transcription and chromatin remodeling pathways. It interacts closely with the transcription factor c-Myc assisting in cell cycle regulation and proliferation. Additionally its presence in the p53 signaling pathway highlights its involvement in controlling cell growth and apoptosis. KAT2A/GCN5 activity influences downstream events in these pathways by affecting the acetylation state of specific histones and non-histone proteins.
Specifications
Form
Liquid
Additional notes
ab111648 is purified using conventional chromatography.
General info
Function
Protein lysine acyltransferase that can act as a acetyltransferase, glutaryltransferase, succinyltransferase or malonyltransferase, depending on the context (PubMed : 29211711, PubMed : 35995428). Acts as a histone lysine succinyltransferase : catalyzes succinylation of histone H3 on 'Lys-79' (H3K79succ), with a maximum frequency around the transcription start sites of genes (PubMed : 29211711). Succinylation of histones gives a specific tag for epigenetic transcription activation (PubMed : 29211711). Association with the 2-oxoglutarate dehydrogenase complex, which provides succinyl-CoA, is required for histone succinylation (PubMed : 29211711). In different complexes, functions either as an acetyltransferase (HAT) or as a succinyltransferase : in the SAGA and ATAC complexes, acts as a histone acetyltransferase (PubMed : 17301242, PubMed : 19103755, PubMed : 29211711). Has significant histone acetyltransferase activity with core histones, but not with nucleosome core particles (PubMed : 17301242, PubMed : 19103755, PubMed : 21131905). Has a a strong preference for acetylation of H3 at 'Lys-9' (H3K9ac) (PubMed : 21131905). Acetylation of histones gives a specific tag for epigenetic transcription activation (PubMed : 17301242, PubMed : 19103755, PubMed : 29211711). Recruited by the XPC complex at promoters, where it specifically mediates acetylation of histone variant H2A.Z.1/H2A.Z, thereby promoting expression of target genes (PubMed : 29973595, PubMed : 31527837). Involved in long-term memory consolidation and synaptic plasticity : acts by promoting expression of a hippocampal gene expression network linked to neuroactive receptor signaling (By similarity). Acts as a positive regulator of T-cell activation : upon TCR stimulation, recruited to the IL2 promoter following interaction with NFATC2 and catalyzes acetylation of histone H3 at 'Lys-9' (H3K9ac), leading to promote IL2 expression (By similarity). Required for growth and differentiation of craniofacial cartilage and bone by regulating acetylation of histone H3 at 'Lys-9' (H3K9ac) (By similarity). Regulates embryonic stem cell (ESC) pluripotency and differentiation (By similarity). Also acetylates non-histone proteins, such as CEBPB, MRE11, PPARGC1A, PLK4 and TBX5 (PubMed : 16753578, PubMed : 17301242, PubMed : 27796307, PubMed : 29174768, PubMed : 38128537). Involved in heart and limb development by mediating acetylation of TBX5, acetylation regulating nucleocytoplasmic shuttling of TBX5 (PubMed : 29174768). Acts as a negative regulator of centrosome amplification by mediating acetylation of PLK4 (PubMed : 27796307). Acts as a negative regulator of gluconeogenesis by mediating acetylation and subsequent inactivation of PPARGC1A (PubMed : 16753578, PubMed : 23142079). Also acts as a histone glutaryltransferase : catalyzes glutarylation of histone H4 on 'Lys-91' (H4K91glu), a mark that destabilizes nucleosomes by promoting dissociation of the H2A-H2B dimers from nucleosomes (PubMed : 31542297).. (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes.
Sequence similarities
Belongs to the acetyltransferase family. GCN5 subfamily.
Post-translational modifications
Acetylated at Lys-549, inhibiting the protein acetyltransferase activity (PubMed:23142079). Deacetylation at Lys-549 by SIRT6 promotes phosphorylation at Ser-307 and Thr-735 and subsequent activation of the protein acetyltransferase activity, leading to acetylation and inactivation of PPARGC1A (PubMed:23142079).
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com